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Sir,
In a recent issue, Robertson et al (2004) reported on the time
from presentation to treatment of colorectal and breast cancers in
Scottish urban and rural areas.
Using as their principal outcome, the time from first presenta-
tion with suspicious symptoms or signs to treatment, there was no
evidence that people living in urban areas received treatment more
quickly. Furthermore, delay did not vary according to hospital type
or distance from residence to the nearest cancer centre. However,
age and number of female GPs (practice level) were significantly
associated with a reduction of delay. In a previous issue, Campbell
et al (2002) found significant difference in the delay between
people living far from a cancer centre (more than 58km) and those
living near a cancer centre (less than 5km).
We recently conducted a similar study focused on people with
colorectal cancer diagnosed in 1995 in five French departments
covered by a cancer registry (Calvados, Ise `re, Manche, Bas-Rhin
and Haut-Rhin). We used as principal outcome the time from first
specialist presentation to treatment (surgery, chemotherapy or
radiotherapy). The main independent variables studied were: road
distance to specialized cancer units (University hospital and cancer
care centre), occupation, marital status, gender, place of residence
(urban vs rural), cancer stage, hospital type, emergency admission
and first specialist referral. Unlike Robertson et al (2004), we
preferred to used the Cox hazard model in order to include in the
analysis patients without treatment (N¼40).
The mean delay was 27.9 days. Since we found no influence
of place of residence (urban vs rural), distance to specialised
cancer centre and occupation on delay, these variables were not
included in the final model. Emergency admission and surgeon
as first specialist referral were associated with a shorter delay
(Table 1). Patients living in Bas-Rhin department had a shorter
delay than patients living in Calvados department. Advanced
stage of cancer (metastases and inoperable) was significantly
associated with longer delay, probably due to a more complex
management.
Health care system and health services are notably different in
France and Scotland. Nevertheless, except for minor details, our
study exhibits results similar to those shown by Robertson and
Campbell: the delay from first presentation to treatment is slightly
shorter in France than in Scotland, but more importantly, in both
Table 1 Time between first specialist referral and treatment (Cox
hazard model final regression)
N¼903 N
Odds
ratio*
95%
confidence
interval
Standard
error
P-
values**
Age
o65 259
65–74 317 1.00 0.84 1.19 0.09 NS
75–84 229 0.99 0.82 1.19 0.10 NS
484 97 0.92 0.71 1.17 0.13 NS
Unknown 1
Sex
Male 491
Female 412 1.07 0.93 1.22 0.07 NS
Cancer stage
Dukes A, B or C 655
Me ´tastasis or not operable 215 0.66 0.56 0.78 0.09 ***
Unknown 33 1.04 0.73 1.48 0.18 NS
Department of residence
Calvados 226
Isere 122 1.09 0.87 1.37 0.12 NS
Manche 186 0.83 0.63 1.11 0.14 NS
Bas-Rhin 192 1.36 1.11 1.66 0.10 ***
Haut-Rhin 177 0.82 0.62 1.09 0.14 NS
Emergency admission
No 756
Yes 130 2.43 1.92 3.08 0.12 ***
Unknown 17 1.21 0.73 2.01 0.26 NS
Type of first referral
Gastro-enterologist 533
Surgeon 138 1.62 1.27 2.05 0.12 ***
Other specialist 113 0.91 0.73 1.14 0.11 NS
Unknown 119 1.09 0.88 1.34 0.11 NS
*Odds ratio higher than unity means a shorter delay before treament. **Significant
levels are: *o0.10; **o0.05; ***o0.01; NS¼not significant.
*Correspondence: G Launoy, Equipe associee INSERM/InVS, Caen
Registre des Tumeurs, Digestives du Calvados CHU, Avenue Cote de
Nacre, Caen Cedex, France; E-mail: launoy@medecine.unicaen.fr
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variables and the delay before treatment.
Social inequalities in cancer survival are well established in
different countries (Auvinen and Karjalainen, 1997). The Scottish
and French data suggest that the delay from presentation to
treatment does not contribute to the social differences in survival.
Further studies are thus needed to confirm the possible contribu-
tion of social differences in access to specialised care centre.
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